1. Austin PF, Bauer SB, Bower W, Chase J, Franco I, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children’s Continence Society. Neurourol Urodyn. 35:471–481. 2016.
Article
2. Bauer SB, Austin PF, Rawashdeh YF, de Jong TP, Franco I, Siggard C, et al. International Children’s Continence Society’s recommendations for initial diagnostic evaluation and follow-up in congenital neuropathic bladder and bowel dysfunction in children. Neurourol Urodyn. 31:610–614. 2012.
Article
3. Bauer SB, Nijman RJ, Drzewiecki BA, Sillen U, Hoebeke P; International Children’s Continence Society Standardization Subcommittee. International Children’s Continence Society standardization report on urodynamic studies of the lower urinary tract in children. Neurourol Urodyn. 34:640–647. 2015.
Article
4. Chang SJ, Chiang IN, Hsieh CH, Lin CD, Yang SS. Age- and gender-specific nomograms for single and dual post-void residual urine in healthy children. Neurourol Urodyn. 32:1014–1018. 2013.
Article
5. Light JK, Faganel J, Roth DR, Dimitrijevic MR. Meningomyelocele: a clinical, urodynamic and neurophysiological evaluation. J Urol. 131:717–721. 1984.
Article
6. MacLellan DL. Neuromuscular dysfunction of the lower urianry tract in children. In : Wein AJ, Kavoussi LR, Partin AW, Peters C, editors. Campbell-Walsh urology. Philadelphia: Elsevier;2016. 4.
7. Madersbacher H. The various types of neurogenic bladder dysfunction: an update of current therapeutic concepts. Paraplegia. 28:217–229. 1990.
Article
8. Stein R, Bogaert G, Dogan HS, Hoen L, Kocvara R, Nijman RJM, et al. EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part I diagnostics and conservative treatment. Neurourol Urodyn. 39:45–57. 2020.
Article
9. Verpoorten C, Buyse GM. The neurogenic bladder: medical treatment. Pediatr Nephrol. 23:717–725. 2008.
Article